FDA approves Rapivab to treat flu infection
On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults.
-
Subscribe
Subscribe via the RSS feed
On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults.